Should Thromboprophylactic Dosage of Low Molecular Weight Heparin Be Adapted to Patient’s Weight?

• References

• 1 Kakkar VV, Djazaeri B, Fok J, Fletcher M, Scully MF, Westwick J. Low molecular-weight heparin and prevention of postoperative deep vein thrombosis. Br Med J 1982; 284: 375-9
• 2 Kakkar VV, Murray WJG. Efficacy and safety of low molecular-weight heparin (CY 216) in preventing postoperative venous thromboembolism: A co-operative study.. Br J Surg 1985; 72: 786-91
• 3 Schmitz-Huebner U, Bunte H, Freise G, Reers B, Ruschemeyer C, Scherer R, Schulte H, Van de Loo J. Clinical efficacy of low molecular weight heparin in postoperative thrombosis prophylaxis. Klin Wochenschr 1984; 62: 349-53
• 4 Bergqvist D, Burmark US, Frisell J, Hallbook T, Lindblad B, Risberg B, Torngren S, Wallin G. Low molecular weight heparin once daily compared with conventional low-dose heparin twice daily. A prospective double-blind multicentre trial on prevention of postoperative thrombosis.. Br J Surg 1986; 73: 204-8
• 5 Aiach M, Leon M, Michaud A, Capron L. Adaptation of synthetic peptide substrate-based assays on a discrete analyser. Semin Thromb Hemost 1983; 9: 206-15
• 6 Koller M, Schoch U, Buchmann P, Largiader F, von Felten A, Frick PG. Low molecular weight heparin (KABI 2165) as thromboprophylaxis in elective visceral surgery. A randomized, double-blind study versus unfractionated heparin. Thromb Haemostas 1986; 56: 243-6